Damora Therapeutics (DMRA) Preferred Dividend Payments (2019 - 2020)

Damora Therapeutics' (DMRA) quarterly Preferred Dividend Payments came in at $2.7 million in Q3 2020, up 93.65% YoY from $1.4 million in Q4 2019, and up 93.65% on a QoQ basis from $1.4 million in Q4 2019.

Damora Therapeutics (DMRA) Preferred Dividend Payments (2019 - 2020) Analysis & Trends

Damora Therapeutics (DMRA) has 2 years of Preferred Dividend Payments data on file, last reported at $2.7 million in Q3 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Pref Dividends (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn -
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn -
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn -
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -
7 Royalty Pharma 33.72 Bn 35.84 Bn - -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn -
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn -
10 Damora Therapeutics 1.92 Bn 1.38 Bn - -

Historic Data

Download Data
DateValue
Sep 30, 2020 2.71 Mn
Dec 31, 2019 1.40 Mn
Sep 30, 2019 1.40 Mn